Skip to content

Evaluation of the effect of using abdominal binder on the amount of vaginal bleeding, pain intensity and mobility after cesarean section

Evaluation of the effect of using abdominal binder on the amount of vaginal bleeding, pain intensity and mobility after cesarean section

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20211024052856N1
Enrollment
184
Registered
2021-11-08
Start date
2021-11-11
Completion date
Unknown
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delivery by elective cesarean section. Encounter for cesarean delivery without indication

Interventions

Intervention 1: In the intervention group, in addition to routine care, the patient's abdomen will be closed with a abdominal binder( Paksaman, made in iran) after cesarean section, besides receiving
then, according to the abdominal circumference, in abdominal circumference fastened for 24 houre after transfer of the patient to the surgery ward. abdominal binder will close in 24 hours. At the end

Sponsors

Esfahan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Spinal anesthesia Do not use anti-anxiety and hypnotic drugs and painkillers No underlying disease (neuromuscular disorders, hypertension, kidney disease, heart disease) BMI between 18/5 to 29/5 Term baby Uncomplicated pregnancy such as absence of eclampsia and preeclampsia Do not have any coagulation disorders or use anticoagulants Pfannenstiel incision on the skin and kerr incision on the uterus

Exclusion criteria

Exclusion criteria: Intolerance of the abdominal binder by the patient Reluctance to continue participating in the study Severe postoperative bleeding Damage to body tissues during cesarean section such as damage to the urinary tract and gastrointestinal tract

Design outcomes

Primary

MeasureTime frame
Pain. Timepoint: 6 hours after intervention, 12 hours after intervention, 18 hours after intervention and 24 hours after intervention. Method of measurement: Visual analog scale.;The amount of vaginal bleeding. Timepoint: Before intervention, 6 and 24 hours after intervention. Method of measurement: Measurement of hemoglobin and hematocrit using Complete Blood Count test.;Mobility. Timepoint: 12 and 24 hours after the intervention. Method of measurement: Six minute walk test.

Secondary

MeasureTime frame
Painkillers. Timepoint: 6, 12, 18 and 24 hours after the intervention. Method of measurement: Registration in the questionnaire based on patient records.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSoheila Bakhtiari

Esfahan University of Medical Sciences

bakhtiari@nm.mui.ac.ir+98 31 3792 7510

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026